Fairvalue-Calculator Fairvalue-Calculator
EN DE

Aelis Farma SA (AELIS) Fair Value & Analysis

Healthcare · FR · Market cap €17.2M

Price€0.9980
Fair Value€1.47
Upside+47.3%
Quality95/100
Evidence: Low Range €1.10 – €1.83

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Aelis Farma SA (AELIS) currently trades at €0.9980, while our model-based Fair Value estimate is €1.47 — implying the stock looks roughly 47.3% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

Aelis Farma SA, a clinical-stage biopharmaceutical company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders in France. The company is developing signaling-specific inhibitors of the CB1 receptors, such as AEF0117, a drug candidate, which is in Phase 2b clinical trials for the treatment of the harmful effects of excessive cannabis use; and AEF0217, a drug candidate, which is in phase II clinical trials to treat cognitive deficits observed in down syndrome, as well as other cognitive impairments. Aelis Farma SA was incorporated in 2013 and is headquartered in Bordeaux, France.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -88% Regeneron Pharmaceuticals, Inc (REGN) -14% UCB SA (UCB) -27% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +9% Alnylam Pharmaceuticals, Inc (ALNY) -62%

Frequently asked questions

Is Aelis Farma SA (AELIS) undervalued?
As of Jun 24, 2026, our model estimates a fair value of €1.47 versus a price of €0.9980 — about +47% (undervalued). Model-based estimate, not financial advice.
What is the fair value of AELIS?
Our 21-model fair value for Aelis Farma SA is €1.47 (as of Jun 24, 2026), built from audited fundamentals. The current price is €0.9980.
What is the quality score of AELIS?
Aelis Farma SA has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.